↓ Skip to main content

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

Overview of attention for article published in Breast Cancer Research, July 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
18 X users

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
54 Mendeley